Randy Noranbrock
Condensed IP
An AI-generated, human-curated podcast for brief discussions of US court decisions on Intellectual Property topics.
Author
Randy Noranbrock
Category
Podcast website
Latest episode
Jul 10, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
IBM v. Zillow (Fed. Cir., December 9, 2025) 2024-1170 10.12.2025 10:28
This episode covers an opinion from the United States Court of Appeals for the Federal Circuit regarding a patent dispute between International Business Machines Corporation (IBM), the appellant, and Zillow Group, Inc., and Zillow, Inc. (Zillow), the cross-appellants. The appeal and cross-appeal stem from a decision by the Patent Trial and Appeal Board (Board) concerning the patentability of claim...
Coda v. Goodyear Tire & Rubber (Fed. Cir., December 8, 2025) 2023-1880 09.12.2025 9:09
This episode is about an opinion from the United States Court of Appeals for the Federal Circuit regarding the appeal in the case of Coda Development S.R.O. v. Goodyear Tire & Rubber Company, which revolves around claims of trade secret misappropriation and a denial for the correction of inventorship for a Goodyear patent related to self-inflating tire (SIT) technology. The plaintiffs, collect...
Adnexus v Meta Platforms (Fed. Circ., December 5, 2025) 2024-1551 08.12.2025 10:44
This episode is about an opinion from the United States Court of Appeals for the Federal Circuit regarding the case of Adnexus Inc. v. Meta Platforms, Inc., which concerns a patent infringement lawsuit. Adnexus, the plaintiff-appellant, appealed the dismissal of its lawsuit against Meta for failure to state a claim, specifically focusing on whether Meta’s "Lead Ads" product infringed on...
Seagen v Daiichi Sankyo (Fed. Cir., December 2, 2025) 2023-2424 03.12.2025 12:30
This episode presents an opinion from the United States Court of Appeals for the Federal Circuit, resolving a patent dispute between Seagen Inc. and Daiichi Sankyo Company, Ltd. concerning an antibody-drug conjugate (ADC) cancer treatment. Seagen had previously secured a jury verdict in the Eastern District of Texas finding that Daiichi's drug, Enhertu®, willfully infringed the ’039 patent an...
In Re Gesture Technology (Fed. Cir., December 1, 2025) 2025-1075 02.12.2025 9:28
This episode is about an Opinion from the United States Court of Appeals for the Federal Circuit (CAFC) in 2025, addressing an appeal by Gesture Technology Partners, LLC concerning the unpatentability of its ’431 patent. The case centered on an ex parte reexamination that proceeded despite the existence of two related inter partes reviews (IPRs) that had already found most claims invalid. Gesture...
EscapeX v. Google (Fed. Cir., November 25, 2025) 2024-1201 30.11.2025 9:46
This episode concerns an opinion from the United States Court of Appeals for the Federal Circuit addressing the appeal filed by EscapeX IP, LLC against a series of sanction rulings granted in favor of Google LLC. The court affirmed the district court’s determination that the patent infringement case against Google was "exceptional" under 35 U.S.C. § 285, largely because EscapeX failed to...
Akamai Technologies v. Mediapointe, Inc., AMHC, Inc. (Fed. Cir., November 25, 2025) 2024-1571 26.11.2025 9:05
This episode presents an opinion from the United States Court of Appeals for the Federal Circuit in a patent dispute involving Akamai Technologies, Inc. and MediaPointe, Inc. The appeal centered on patents describing an "intelligent distribution network" for streaming media, with the appellate court affirming the lower court’s final judgment on all contested issues. The court upheld the...
Duke University v. Sandoz Inc. (Fed. Cir., November 18, 2025) 2024-1078 19.11.2025 8:59
This episode regards an opinion from the United States Court of Appeals for the Federal Circuit in the case of Duke University v. Sandoz Inc., decided on November 18, 2025. The core issue is an appeal from Sandoz regarding a lower court's judgment that upheld the validity of claim 30 of U.S Patent No. 9,579,270, which relates to using specific prostaglandin F analogs for treating hair loss. D...
Smartrend v. Opti-Luxx Patent Appeals (Fed. Cir., November 13, 2025) 2024-1616 17.11.2025 7:43
This episode covers an opinion from the United States Court of Appeals for the Federal Circuit regarding a patent infringement case between Smartrend Manufacturing Group (SMG), Inc., and Opti-Luxx Inc. This judicial decision addresses two separate patents related to illuminated school bus signs, a design patent (D930) and a utility patent (’491). For the D930 patent, the appellate court vacates th...
Canatex Completion Solutions v. Wellmatics (Fed. Cir., November 12, 2025) 2024-1466 14.11.2025 11:52
This episode is about an opinion from the United States Court of Appeals for the Federal Circuit in the case of Canatex Completion Solutions, Inc. v. Wellmatics, LLC, decided on November 12, 2025. The core issue of the appeal is whether the U.S. Patent No. 10,794,122, owned by Canatex, is invalid for indefiniteness due to an alleged clerical error in the claims. Specifically, the patent uses the p...
In Re Motorola Solutions, Inc (Fed. Cir., November 6, 2025) 2025-134 10.11.2025 10:21
This episode is about a judicial order from the United States Court of Appeals for the Federal Circuit dated November 6, 2025, concerning the case In Re MOTOROLA SOLUTIONS, INC. The court addresses Motorola Solutions' Petition for Writ of Mandamus against the United States Patent and Trademark Office (PTO) following the PTO's de-institution of several inter partes reviews (IPRs) involvin...
Merck Serono v. Hopewell Pharma (Fed. Cir., October 30, 2025) 2025-1210 03.11.2025 11:02
This episode regards a United States Court of Appeals for the Federal Circuit opinion, dated October 30, 2025, concerning a patent dispute between Merck Serono S.A. and Hopewell Pharma Ventures, Inc. The case involves Merck's appeal of two consolidated inter partes reviews (IPRs) before the Patent Trial and Appeal Board (Board), which had found certain claims of two Merck patents related to a...
Aortic Innovations v. Edwards Lifesciences (Fed. Cir., October 27, 2025) 2024-1145 28.10.2025 11:31
This episode relates to a United States Court of Appeals for the Federal Circuit opinion regarding a patent infringement case, Aortic Innovations LLC v. Edwards Lifesciences Corporation decided October 27, 2025. The core dispute involves the correct claim construction of the term "outer frame" in patents concerning transcatheter aortic valve replacement devices. The Plaintiff-Appellant,...
Centripetal Networks v. Palo Alto Networks (Fed. Cir., October 22, 2025) 2023-2027 23.10.2025 12:27
This episode concerns a decision from the United States Court of Appeals for the Federal Circuit regarding Centripetal Networks, LLC v. Palo Alto Networks, Inc. et al., decided on October 22, 2025. The core of the case involves Centripetal Networks appealing a decision by the Patent Trial and Appeal Board (PTAB) that held certain claims of their patent unpatentable as obvious. A significant issue...
Barrette Outdoor Living v. Fortress Iron (Fed. Cir., October 17, 2025) 2024-1231 22.10.2025 10:37
This episode focuses on an opinion by the United States Court of Appeals for the Federal Circuit, concerning a patent infringement case between Barrette Outdoor Living, Inc. (Plaintiff-Appellant) and Fortress Iron, LP, et al. (Defendants-Cross-Appellants). Barrette appealed a lower court's finding of non-infringement related to four of its patents, while Fortress cross-appealed the finding th...
Causam v. ecobee (Fed. Cir., October 15, 2025) 2024-1958 21.10.2025 12:15
This episode concerns the United States Court of Appeals for the Federal Circuit's opinion in the case of Causam Enterprises, Inc. v. ecobee Technologies ULC, decided on October 15, 2025. The core issue is an appeal from a decision by the Patent Trial and Appeal Board (Board), which had ruled that several claims of Causam's U.S. Patent No. 10,394,268 were unpatentable due to obviousness...
Causam v. ITC (Fed. Cir., October 15, 2025) 2023-1769 21.10.2025 10:37
This episode details an opinion from the United States Court of Appeals for the Federal Circuit regarding an appeal in the case of Causam Enterprises, Inc. v. International Trade Commission (ITC). The core issue originated from Causam's complaint to the ITC alleging that various companies, including Resideo Smart Homes Technology and ecobee Technologies ULC, were violating a section of the Ta...
Inland Diamond Products v Cherry Optical (Fed. Cir., October 15, 2025) 2024-1106 16.10.2025 10:08
This opinion from the United States Court of Appeals for the Federal Circuit, dated October 15, 2025, concerns the case of Inland Diamond Products Co. v. Cherry Optical Inc. The court addresses an appeal from the U.S. District Court for the Eastern District of Wisconsin, which had granted summary judgment that Inland’s asserted patent claims were invalid for obviousness based on the doctrine of is...
Brita v. ITC (Fed. Cir., October 15, 2025) 2024-1098 16.10.2025 11:01
This opinion from the United States Court of Appeals for the Federal Circuit, dated October 15, 2025, concerns the patent infringement case of Brita LP v. International Trade Commission (ITC). The court is reviewing Brita's appeal of an ITC decision that found certain claims of Brita's U.S. Patent No. 8,167,141 invalid. Specifically, the patent relates to gravity flow filter media design...
US Inventor v. USPTO (Fed. Cir., October 3, 2025) 2024-1396 08.10.2025 10:34
This episode is about a United States Court of Appeals for the Federal Circuit opinion, decided on October 3, 2025, concerning the case of US Inventor, Inc. v. United States Patent and Trademark Office (PTO). The core issue of the appeal was whether the plaintiffs-appellants, US Inventor, Inc. and National Small Business United, had standing to sue the PTO for denying their petition for rulemaking...
Rex Medical v. Intuitive Surgical (Fed. Cir., October 2, 2025) 2024-1072 03.10.2025 10:41
This episode concerns a decision from the United States Court of Appeals for the Federal Circuit regarding a patent infringement case, Rex Medical, L.P. v. Intuitive Surgical, Inc. The core issues addressed are damages, infringement, and patent validity of U.S. Patent No. 9,439,650, which relates to surgical stapling systems. The Federal Circuit ultimately affirmed the district court’s rulings, sp...
Focus Products Group v Kartri Sales (Fed. Cir., September 30, 2025) 2023-1446 01.10.2025 11:39
This episode is about an opinion from the United States Court of Appeals for the Federal Circuit, decided on September 30, 2025, concerning a complex intellectual property dispute between Focus Products Group International, LLC (and several related entities, collectively Appellees) and Kartri Sales Co., Inc. and Marquis Mills, International, Inc. (Appellants). The case centers on allegations that...
Apex Bank v. CC Serve (Fed. Cir., September 25, 2025) 2023-2143 26.09.2025 12:25
This episode concerns a decision from the United States Court of Appeals for the Federal Circuit. The court opinion, Apex Bank v. CC Serve Corp., decided on September 25, 2025, addresses an appeal from the Trademark Trial and Appeal Board regarding the likelihood of confusion between the ASPIRE mark used by CC Serve and the proposed ASPIRE BANK marks of Apex Bank. The Federal Circuit affirmed-in-p...
Finesse Wireless v. AT&T Mobility (Fed. Cir., September 24, 2025) 2024-1039 25.09.2025 10:34
This episode concerns an opinion from the United States Court of Appeals for the Federal Circuit regarding the case of Finesse Wireless LLC v. AT&T Mobility LLC and others. The court addresses an appeal by the defendants, AT&T and Nokia, against a district court's denial of Judgment as a Matter of Law (JMOL) regarding the noninfringement of U.S. Patent Nos. 7,346,134 and 9,548,775, wh...
Bayer v. Mylan (Fed. Cir., September 23, 2025) 2023-2434 24.09.2025 10:44
This opinion from the United States Court of Appeals for the Federal Circuit concerns a patent infringement appeal case, Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc. The appeal concerns the Patent Trial and Appeal Board's (PTAB) final written decision holding claims of Bayer's U.S. Patent No. 10,828,310, which describes methods using rivaroxaban and aspirin to reduce car...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.